• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Recurrence of atrial fibrillation after switching from brand to generic atenolol.从品牌阿替洛尔转换为通用阿替洛尔后房颤复发。
J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):39-41. doi: 10.4103/0976-500X.149146.
2
Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline.从品牌名西苯唑啉转换为通用名西苯唑啉后房性和室性早搏的表现
Cureus. 2023 Jun 29;15(6):e41164. doi: 10.7759/cureus.41164. eCollection 2023 Jun.
3
Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.在心房颤动患者中，华法林制剂转换所带来的资源利用和成本影响。
Ann Pharmacother. 2012 Dec;46(12):1609-16. doi: 10.1345/aph.1Q472. Epub 2012 Nov 13.
4
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.慢性房颤患者日常活动及程控运动期间的心室率控制：五种药物治疗方案的交叉开放标签研究
J Am Coll Cardiol. 1999 Feb;33(2):304-10. doi: 10.1016/s0735-1097(98)00561-0.
5
[Pharmacologic treatment of atrial fibrillation].[心房颤动的药物治疗]
Pol Merkur Lekarski. 2008 Oct;25(148):303-8.
6
The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery.
Eur Heart J. 1988 Jan;9(1):32-6.
7
The relation between supraventricular tachyarrhythmias and left ventricular dysfunction after acute myocardial infarction.急性心肌梗死后室上性快速心律失常与左心室功能障碍之间的关系。
Acta Cardiol. 1988;43(6):689-701.
8
Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic.通用型与品牌型β受体阻滞剂在左心室射血分数降低的心力衰竭患者中的临床耐受性：一项来自心力衰竭诊所的回顾性队列研究
J Drug Assess. 2018 Jan 11;7(1):8-13. doi: 10.1080/21556660.2018.1423988. eCollection 2018.
9
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.与阿替洛尔相比，血管紧张素II受体阻滞剂可降低新发房颤及后续卒中风险：氯沙坦干预降低高血压终点事件研究（LIFE研究）。
J Am Coll Cardiol. 2005 Mar 1;45(5):712-9. doi: 10.1016/j.jacc.2004.10.068.
10
Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism.比较左甲状腺素治疗甲状腺功能减退症的通用和品牌制剂的心血管不良事件发生率。
Mayo Clin Proc. 2019 Jul;94(7):1190-1198. doi: 10.1016/j.mayocp.2018.11.030. Epub 2019 Apr 26.

引用本文的文献

1
Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective study.氟卡尼耐受性良好，对房颤患者12个月时有效：一项回顾性研究。
Ther Adv Cardiovasc Dis. 2020 Jan-Dec;14:1753944720926824. doi: 10.1177/1753944720926824.

本文引用的文献

1
Skin rash during treatment with generic itraconazole.使用通用型伊曲康唑治疗期间出现皮疹。
J Pharmacol Pharmacother. 2014 Apr;5(2):158-60. doi: 10.4103/0976-500X.130086.
2
Pharmacokinetic drug-drug interaction and their implication in clinical management.药代动力学药物相互作用及其在临床管理中的意义。
J Res Med Sci. 2013 Jul;18(7):601-10.
3
Cardiometabolic risk factors and atrial fibrillation.心血管代谢危险因素与心房颤动。
Rev Cardiovasc Med. 2013;14(2-4):e73-81. doi: 10.3909/ricm0693.
4
Comparative pharmaceutical evaluation of brand and generic clobetasone butyrate ointments.品牌和通用型丁酸氯倍他松软膏的比较药学评价
Int J Pharm. 2014 Mar 10;463(1):62-7. doi: 10.1016/j.ijpharm.2013.12.054. Epub 2014 Jan 7.
5
A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study.一项队列研究检查心房颤动的既定和新兴风险因素：巴瑟尔顿健康研究。
Eur J Epidemiol. 2014 Mar;29(3):181-90. doi: 10.1007/s10654-013-9875-y. Epub 2014 Jan 4.
6
Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy.非专利通用药物与六种参照药物的非专利品牌药物对比：来自意大利伦巴第大区五个地方医疗机构的回顾性理赔数据研究。
PLoS One. 2013 Dec 18;8(12):e82990. doi: 10.1371/journal.pone.0082990. eCollection 2013.
7
Risk factors for new-onset atrial fibrillation.
Int J Cardiol. 2014 Feb 1;171(2):e46. doi: 10.1016/j.ijcard.2013.11.115. Epub 2013 Dec 6.
8
Safety and efficacy of generic drugs with respect to brand formulation.仿制药相对于品牌制剂的安全性和有效性。
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S110-4. doi: 10.4103/0976-500X.120972.
9
Lack of efficacy during the switch from brand to generic allopurinol.从品牌别嘌醇转换为通用别嘌醇期间缺乏疗效。
J Forensic Leg Med. 2013 Jul;20(5):540-2. doi: 10.1016/j.jflm.2013.02.007. Epub 2013 Mar 7.
10
Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies.21 世纪的心房颤动：对危险因素和初级预防策略的最新认识。
Mayo Clin Proc. 2013 Apr;88(4):394-409. doi: 10.1016/j.mayocp.2013.01.022.

从品牌阿替洛尔转换为通用阿替洛尔后房颤复发。

Recurrence of atrial fibrillation after switching from brand to generic atenolol.

作者信息

Gallelli Luca, Maida Francesca, Staltari Orietta, Rende Pierandrea, Russo Emilio, Caroleo Benedetto, De Sarro Giovambattista

机构信息

Department of Health Science, University of Catanzaro, Catanzaro, Italy.

出版信息

J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):39-41. doi: 10.4103/0976-500X.149146.

DOI:10.4103/0976-500X.149146
PMID:25709353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4319249/
Abstract

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

摘要

β受体阻滞剂是无心肌梗死或左心室功能障碍病史患者室上性快速心律失常心率控制的初始治疗药物。在本文中，我们报告了换用阿替洛尔通用制剂后房颤复发的情况。